Cargando…

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome

OBJECTIVE—Dysregulated apolipoprotein (apo)C-III metabolism may account for hypertriglyceridemia and increased cardiovascular risk in the metabolic syndrome. This study investigated the dose-dependent effect of rosuvastatin on VLDL apoC-III transport in men with the metabolic syndrome. RESEARCH DESI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ooi, Esther M.M., Watts, Gerald F., Chan, Dick C., Chen, Meifania M., Nestel, Paul J., Sviridov, Dmitri, Barrett, P. Hugh R.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2008
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494658/ https://www.ncbi.nlm.nih.gov/pubmed/18509206 http://dx.doi.org/10.2337/dc08-0358

Ejemplares similares

Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome
por: van der Ham, Rachel L.M., et al.
Publicado: (2009)

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
por: Chan, Dick C., et al.
Publicado: (2010)

Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
por: Sveen, Kari Anne, et al.
Publicado: (2021)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Insulin Resistance and Hyperinsulinemia: You can't have one without the other
por: Kim, Sun H., et al.
Publicado: (2008)

Predictors of arterial stiffness in adolescents and adults with type 1 diabetes: a cross-sectional study
por: Love, Kaitlin M, et al.
Publicado: (2022)

Hyperglycemia and Stroke Mortality: Comparison between fasting and 2-h glucose criteria
por: Hyvärinen, Marjukka, et al.
Publicado: (2009)

Value of Urinary Albumin-to-Creatinine Ratio as a Predictor of Type 2 Diabetes in Pre-Diabetic Individuals
por: Friedman, Allon, et al.
Publicado: (2008)

Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2022)

Blood Pressure and Fasting Plasma Glucose Rather Than Metabolic Syndrome Predict Coronary Artery Calcium Progression: The Rancho Bernardo Study
por: Kramer, Caroline K., et al.
Publicado: (2009)

Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program
por: Perreault, Leigh, et al.
Publicado: (2008)

High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease
por: Zuber, Verena, et al.
Publicado: (2020)

Association of Lifestyle Factors With Abdominal Subcutaneous and Visceral Adiposity: The Framingham Heart Study
por: Molenaar, Esther A., et al.
Publicado: (2009)

Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
por: Crandall, Jill P, et al.
Publicado: (2017)

Changes in Risk Variables of Metabolic Syndrome Since Childhood in Pre-Diabetic and Type 2 Diabetic Subjects: The Bogalusa Heart Study
por: Nguyen, Quoc Manh, et al.
Publicado: (2008)

Diabetes with poor-control HbA1c is cardiovascular disease ‘risk equivalent’ for mortality: UK Biobank and Hong Kong population-based cohort study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
por: Charytan, David M, et al.
Publicado: (2023)

Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia
por: Bello, Natalie A, et al.
Publicado: (2014)

Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial
por: Shestakova, Marina, et al.
Publicado: (2023)

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial
por: Lexis, Chris P H, et al.
Publicado: (2015)

Preanalytical, Analytical, and Computational Factors Affect Homeostasis Model Assessment Estimates
por: Manley, Susan E., et al.
Publicado: (2008)

Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study
por: Bebu, Ionut, et al.
Publicado: (2019)

High Blood Pressure Before and During Early Pregnancy Is Associated With an Increased Risk of Gestational Diabetes Mellitus
por: Hedderson, Monique M., et al.
Publicado: (2008)

Low Serum Vitamin D Levels Are Associated With Increased Arterial Stiffness in Youth With Type 2 Diabetes
por: Jha, Pranati, et al.
Publicado: (2015)

Patterns of Abdominal Fat Distribution: The Framingham Heart Study
por: Pou, Karla M., et al.
Publicado: (2009)

Sedentary Time and Metabolic Risk in Extremely Active Older Adults
por: Madden, Kenneth M., et al.
Publicado: (2021)

Cardiac structure and function with and without metabolic syndrome: the Echocardiographic Study of Latinos (Echo-SOL)
por: Burroughs Peña, Melissa, et al.
Publicado: (2018)

Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study
por: Shah, Amy S., et al.
Publicado: (2017)

The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model
por: Pantalone, Kevin M., et al.
Publicado: (2020)

Association of physiological and psychological health outcomes with physical activity and sedentary behavior in adults with type 2 diabetes
por: Garcia, Jeanette M, et al.
Publicado: (2017)

Association Between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
por: Cheung, Bernard M.Y., et al.
Publicado: (2008)

Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: Synergistic effect of inflammation and hyperglycemia
por: Trøseid, Marius, et al.
Publicado: (2009)

Coronary artery disease in patients with atypical chest pain with and without diabetes mellitus assessed with coronary CT angiography
por: Krul, Marije M G, et al.
Publicado: (2014)

Sex Differences in the Risk of Coronary Heart Disease Associated With Type 2 Diabetes: A Mendelian Randomization Analysis
por: Peters, Tricia M., et al.
Publicado: (2021)

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD
por: Belalcazar, L. Maria, et al.
Publicado: (2015)

Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study
por: Shah, Amy S., et al.
Publicado: (2019)

Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014)

Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis
por: McMillan, Jacqueline M, et al.
Publicado: (2018)

Ideal Cardiovascular Health and the Prevalence and Progression of Coronary Artery Calcification in Adults With and Without Type 1 Diabetes
por: Alman, Amy C., et al.
Publicado: (2014)

Effect of high-salt diet on blood pressure and body fluid composition in patients with type 1 diabetes: randomized controlled intervention trial
por: Wenstedt, Eliane F E, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_prbeirag3c063b0rdol1uklks6